No fewer than six prominent hospitals have consented to withhold gender-affirming hormones and surgical interventions from transgender adolescents, and have likewise agreed to remit payments to the federal government, as stipulated by agreements reached with the Department of Justice.

It was but last week that the most recent agreements were concluded.

The preponderance of hospitals had already ceased administering the treatments, whether by dint of state prohibitions or owing to antecedent pressure exerted by President Donald Trump's administration.

The DOJ agreements conclude investigations into care previously rendered and foreclose the prospect of hospitals being compelled to surrender patient records.

The Justice Department says some providers have also agreed to help defray medical costs for children to “detransition.”

The hospitals have not acknowledged any wrongdoing.

“It constitutes a profoundly perilous precedent when the federal government is permitted to politicize any single group of people’s care and terminate it,” said Eliel Cruz, a cofounder of the Gender Liberation Movement.

Herein lies a scrutiny of the situation:

The Justice Department announced last week that it had reached settlements with New York University Langone Hospitals and the University of Pittsburgh Medical Centers.

The hospitals consented to refrain from administering puberty blockers, hormones or gender-affirming surgery — all of which the administration designates “sex-rejecting procedures” — to patients under 19.

"The Department of Justice is waging a battle to safeguard our nation's children and labouring indefatigably to forge accords with hospitals aimed at abolishing so-called 'gender-affirming care' for minors," U.S. Attorney General Todd Blanche declared in a statement last week.

NYU consented to remit $8.5 million to the federal government, while UPMC consented to remit $950,000 under the agreements, which came on the heels of comparable settlements concluded since May with Cleveland Clinic, Connecticut Children’s Hospital, Mount Sinai Health System in New York, and Texas Children’s Hospital.

The hospitals have asserted that the deals will not impinge upon the manner in which their pediatric mental healthcare programs treat transgender children.

The Trump administration, in the preceding year, promulgated a review advocating exclusively for therapeutic intervention, to the exclusion of more comprehensive gender-affirming care, for young people.

Nevertheless, the preponderance of major medical organizations—among them the American Medical Association and the American Academy of Pediatrics—endorse the continued availability of such treatment.

Mount Sinai stands alone among the six institutions in having struck deals thus far despite not having previously announced its decision.

In Texas and Ohio, hospitals had already ceased providing such care pursuant to statewide prohibitions.

The remainder had promulgated policy revisions only after Trump, upon resuming office in January 2025, embarked upon a succession of measures aimed squarely at the treatment.

That same month, he signed an executive order directing the curtailment of federal support for gender transitions among those under 19, and his administration has since prohibited federal Medicaid funds from defraying the cost of the treatment.

Such care remains obtainable across a heterogeneous array of hospitals and clinics, as well as by way of individual physicians.

One pivotal measure undertaken by the administration was the issuance of subpoenas to hospitals — a move first disclosed in July 2025 — compelling the production of information pertaining to gender-affirming care for children, inclusive of patients' names.

NYU Langone asserted in a statement that acceding to the settlement safeguards patients and their families by eliminating “the threat that NYU Langone would have to provide the confidential information previously demanded about patients under 18 who received gender-affirming care at our institution.”

Several hospitals have petitioned the courts to shield them from being compelled to surrender the records, and the majority prevailed in district courts.

Yet a ruling handed down last month by an appellate court lent considerable impetus to the government's case.

A 2-1 ruling handed down by the San Francisco-based 9th U.S. Circuit Court of Appeals determined that the administration's objective of terminating gender-affirming care for youth is not improper and cannot be invoked as grounds to halt the subpoenas.

No fewer than 27 states have enacted legislation that either circumscribes or outright prohibits gender-affirming care for minors.

Moreover, in excess of two dozen hospitals, health systems and clinics situated in states devoid of bans have ceased providing the care since last year — including several in states that afford it explicit legal protections.

A cohort of Democratic state officials has instituted legal proceedings against the Trump administration on that account, contending that its endeavours unlawfully intimidate medical providers.

Gender-affirming surgery among individuals under the age of 18 remains a rarity; nonetheless, a substantial number of transgender adolescents undergo hormonal interventions either to suppress puberty or to induce the development of sex-linked characteristics consonant with their gender identity.

Cruz’s Gender Liberation Movement has picketed hospitals that have discontinued the provision of such care.

Cruz observed that certain families have relocated to other states in pursuit of access to treatment, only to discover that providers there, too, have ceased offering it.

Some, he noted, have departed the country altogether.

He asserted that the agreements concluded with the Trump administration evince “who has the courage to do what their calling and education calls them to do — which is do no harm — and those (who do) not.”

The story has been revised to rectify the assertion that the agreements stipulate that hospitals remit payment to the federal government, rather than that the government be paid to reverse transitions.